Skip to search formSkip to main contentSkip to account menu

Fesoterodine Fumarate

Known as: 2-((1R)-3-(Diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl Isobutyrate 
The fumarate salt form of fesoterodine, a competitive muscarinic receptor antagonist with muscle relaxant and urinary antispasmodic properties… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
: The aim of the present study was to develop Sustained release formulation of Fesoterodine Fumarate to maintain constant… 
2014
2014
Email: gktsyadav@gmail.com ABSTRACT Background: The UV spectrophotometric method has been developed for the determination of… 
2012
2012
A chiral liquid chromatographic method was develope d for the enantiomeric purity of Fesoterodine Fumar ate in drug substance as… 
2010
2008
2008
FDA on October 31 announced the U.S. marketing approval of fesoterodine fumarate for the treatment of overactive bladder in…